Physician

Michael L Ingram, MD

According to 2025 Medicare claims, Michael Ingram, MD (NPI: 1679527949) practices radiation oncology in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is CENTRAL ALABAMA RADIATION ONCOLOGY (NPI: 1659644706; TIN: 454048337) and primary practice location at 36106-2801.

Ingram's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 285 traditional Medicare patients, billed 3,320 HCPCS/CPT codes, and received $564,191 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 153 prescription claims across 77 beneficiaries totaling $6,601 in drug costs, led by Mometasone Furoate (Mometasone Furoate). 2016 DME data shows 11 claims. Open Payments data shows 11 records totaling $298. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,248,958 to $564,191. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,569 and ending at $6,601. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.